A pilot-controlled study of a polymyxim B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection

Shock

Volumn 23, Issue 5, 2005, Pages 400-405

  Vincent, Jean Louis ^a   Laterre, Pierre François ^b   Cohen, Jonathan ^c   Burchardi, Hilmar ^d   Bruining, Hajo ^e   Lerma, Francisco Alvarez ^f   Wittebole, Xavier ^b   De Backer, Daniel ^a   Brett, Stephen ^g   Marzo, Dolores ^f   Nakamura, Haruji ^h   John, Stephanie ⁱ  

^a ERASME HOSPITAL   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f HOSPITAL DEL MAR   (Spain)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

^h TORAY INDUSTRIES INC   (Japan)

ⁱ IQVIA   (United States)

Author keywords

Endotoxin; Extracorporeal renal support; Hemodynamics; Organ dysfunction; Polymyxin B; Sepsis

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; POLYMYXIN B; TORAYMYXIN;

ABDOMINAL INFECTION; ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; EUROPE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL HEMOPERFUSION; FEMALE; FEVER; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OXYGEN BLOOD LEVEL; PLEURA EFFUSION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ENDOTOXINS; FEMALE; HEMOPERFUSION; HUMANS; INTERLEUKIN-6; KIDNEY; MALE; MIDDLE AGED; MYOCARDIUM; PERFUSION; PILOT PROJECTS; POLYMYXIN B; SEPSIS; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 20244379132     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000159930.87737.8a     Document Type: Article

References (32)

1. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96, 2001.
2. Power C, Fanning N, Redmond HP: Cellular apoptosis and organ injury in sepsis: a review. Shock 18:197-211, 2002.
3. Opal SM, Huber CE: Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit Care 6:125-136, 2002.
4. Amaral A, Opal SM, Vincent JL: Coagulation in sepsis. Intensive Care Med 30:1032-1040, 2004.
5. Hirasawa H, Oda S, Shiga H, et al.: Endotoxin adsorption or haemodiafiltration in the treatment of multiple organ failure. Curr Opin Crit Care 6:421-425, 2000.
6. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250-1255, 2002.
7. Cohen J, Aslam M, Pusey CD, et al.: Protection from endotoxemia: a rat model for plasmapheresis and specific adsorption with polymyxin B. J Infect Dis 155:690-695, 1987.
8. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167:412-417, 1994.
9. Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, Bisagni P, Giavaresi G, Bolzani R, Giardino R: Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 28:1526-1533, 2000.
10. Kodama M, Tani T, Hanasawa K, et al.: Treatment of sepsis by plasma endotoxin removal: Hemoperfusion using a polymyxin-B immobilized column. J Endotoxin Res 4:293-300, 1997.
11. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K: Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 39:937-947, 2002.
12. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 19:361-368, 2001.
13. Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis. Crit Care Med 32:1662-1668, 2004.
14. ACCP-SCCM Consensus Conference: Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13:818-829, 1985.
16. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, Sprung C, Colardyn FC, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26: 1793-1800, 1998.
17. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS: Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 120:1109-1115, 1985.
18. Cohen J, McConnell JS: Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis 150:916-924, 1984.
19. Bates DW, Parsonnet J, Ketchum PA, Miller EB, Novitsky TJ, Sands K, Hibberd PL, Graman PS, Lanken PN, Schwartz JS, Kahn K, Snydman DR, Moore R, Black E, Platt R: Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin infect Dis 27:582-591, 1998.
20. Maury E, Barakett V, Blanchard H, Guitton C, Fitting C, Vassal T, Chauvin P, Guidet B, Offenstadt G: Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections. J Infect Dis 178:270-273, 1998.
21. Cohen J: The detection and interpretation of endotoxaemia. Intensive Care Med 26(suppl 1):S51-S56, 2000.
22. Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, Rancon F, Bertrand JC: Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 26:538-544, 2000.
23. Tani T: Review of endotoxin-adsorbing direct hemoperfusion therapy using a column containing polymyxin B immobilized fiber. Curr Opin Crit Care 6:416-420, 2000.
24. Aoki H, Hanasawa K, Tani T, et al.: Comparative study between PMX-F and other adsorbents for treatment of septic shock. Therapeutic Plasmapheresis 312:345-350, 1988.
25. Sato T, Orlowski JP, Zborowski M: Experimental study of extracorporeal perfusion for septic shock. ASAIO J 39:M790-M793, 1993.
26. Yamamoto H, Koizumi T, Kaneki T, Fujimoto K, Kubo K, Honda T: Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep. J Endotoxin Res 8:419-426, 2002.
27. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 25:660-668, 2001.
28. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahasi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif Organs 22:1038-1044, 1998.
29. Nakamura T, Ushiyama C, Shoji H, Koide H: Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J 48:41-44, 2002.
30. Fernandes CJ Jr, Akamine N, Knobel E: Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 25:1165-1168, 1999.
31. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, Shimizu H, Matsuo S, Imaizumi H, Maruyama I: Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem 294:73-82, 2001.
32. Hoshiai K, Hattan N, Fukuyama N, Tadaki F, Hida M, Saito A, Nakanishi N, Hattori Y, Nakazawa H: Increased plasma tetrahydrobiopterin in septic shock is a possible therapeutic target. Pathophysiology 7:275-281, 2001.